Brief: Bullfrog AI Holdings Launches A Preclinical Study To Evaluate Efficacy Of Its Drug Candidate BF-114 In Obesity

Bullfrog AI Holdings

06/12/2023 13:24

Dec 6 (Reuters) - Bullfrog AI Holdings, Inc.  BFRG.O :
    * BULLFROG AI HOLDINGS, INC.: LAUNCH OF A PRECLINICAL STUDY
TO
EVALUATE EFFICACY OF ITS DRUG CANDIDATE BF-114 IN OBESITY
    * BULLFROG AI HOLDINGS, INC.: STUDY IS EXPECTED TO BE
COMPLETED IN
Q2 OF 2024

Source text for Eikon:  ID:nGNX6G0w39 
Further company coverage:  BFRG.O 

 ((Reuters.Briefs@thomsonreuters.com;))